Coinspeaker CureVac Announces Proposed U.S. IPO of Common Shares to Raise $245MCureVac B.V., a Dutch biopharmaceutical company, filed for an initial public offering on Friday, with plans to list on Nasdaq under the ticker "CVAC." The company intends to sell over 13 million common shares at around $14 and $16 per share.CureVac Announces Proposed U.S. IPO of Common Shares to Raise $245M